Crinetics Pharmaceuticals, Inc.
CRNXDelisted Sep 1, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001658247
Crinetics Pharmaceuticals, Inc. was delisted on Sep 1, 2026; its insiders filed their last Form 4 on Sep 1, 2026; 267 institutions reported holding it in 13F filings for Q2 2026, worth $4.63B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Crinetics Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 111 | 122 | +11 |
| Shares | 50.6M | 51.4M | +789.9K (+1.6%) |
| Value | $944.5M | $1.01B | +$65.9M (+7.0%) |
New holders (24)
Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (13)
Institutions that held Crinetics Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Suvretta Capital Management, LLC | 1,125,112 | $21.0M |
| Polar Asset Management Partners Inc. | 205,100 | $3.83M |
| Monashee Investment Management LLC | 95,000 | $1.77M |
| Renaissance Technologies LLC | 86,400 | $1.61M |
| Cinctive Capital Management LP | 30,000 | $560.0K |
| Dynamic Technology Lab Private Ltd | 26,071 | $486.0K |
| Qube Research & Technologies Ltd | 10,798 | $201.0K |
| AQR Capital Management LLC | 10,138 | $189.0K |
| DuPont Capital Management Corp | 8,629 | $161.0K |
| Captrust Financial Advisors | 1,192 | $22.0K |
| Simplex Trading, LLC | 552 | $10.0K |
| Benjamin F. Edwards & Company, Inc. | 200 | $4.00K |
| State of Wyoming | 70 | $1.00K |